BNP Levels May Not Be Effective Prognostic Tool for Patients With Cardiogenic Shock Using VADs
While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist devices (VADs).
Source: ajmc.com